According to Golden Finance, biopharmaceutical company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy and plans to invest $5 million in initially to buy Bitcoin. Affected by the news, ATAI's stock price rose briefly. The company's chairman Christian Angermayer said the company initially plans to invest $5 million in Bitcoin, while retaining sufficient cash, short-term securities and public equity to protect the company's operating capital through 2027.